Chad Moles
About Chad Moles
Chad Moles: Co-founder and Chief Science Officer
Chad Moles serves as the Co-founder and Chief Science Officer. In his role, he is responsible for guiding the scientific research and development initiatives within the company. His leadership ensures that the company remains at the forefront of biotechnological innovations and advancements.
Chad Moles' Education in Biotechnology
Chad Moles holds a Master of Arts in Biotechnology from Columbia University. His academic background has provided him with a strong foundation in the field, equipping him with the knowledge and skills necessary to excel in his professional endeavors. His education has played a key role in his current position as Chief Science Officer.
Thesis on Synthetic Genome Engineering by Chad Moles
Chad Moles completed his thesis on synthetic genome engineering during his time at Columbia University. His research focused on developing next-generation vaccines and therapeutics. This work has contributed to the broader field of biotechnology, illustrating his expertise and commitment to innovative scientific solutions.
Chad Moles' Contribution to Viral Vector Research
Chad Moles contributed a chapter to the International Review of Cell and Molecular Biology. His chapter, focusing on viral vectors in cancer immunotherapy, offers valuable insights into the use of viral vectors to enhance cancer treatments. This contribution highlights his specialized knowledge and his contribution to ongoing scientific discourse.
Chad Moles on Regulation of Viral Replication
Chad Moles authored a blog post discussing the regulation of viral replication using RNA aptazymes. The piece delves into the intricate mechanisms of how RNA aptazymes can be employed to control viral replication, showcasing his ability to communicate complex scientific topics to a broader audience. This blog post reflects his proficiency in both research and science communication.